You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
This post has been updated to fix the spelling of Novavax's name.
Vaccine maker Novavax has announced that it has begun a phase III trial of its SARS-CoV-2 vaccine in the UK and plans to begin a US trial next month, the New York Times reports.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Don't have a GenomeWeb or 360Dx account?Register for Free.
The Washington Post reports that US states and territories are seeking more funding for the distribution of SARS-CoV-2 vaccines.
The strain now accounts for about 80 percent of cases in Wales and Scotland, and about half of cases in England, the Guardian reports.
A new study suggests that using CRISPR to edit human embryonic DNA can lead to the loss of whole chromosomes, as the Associated Press reports.
In Science this week: ancient dog genomes highlight long ties with humans, genomic analysis of 40,000-year-old early East Asian individual, and more.